Akzo Pays $28M To Settle Remeron Suits

Law360, New York (April 16, 2004, 12:00 AM EDT) -- Dutch conglomerate company Akzo Nobel and its subsidiary Organon USA have agreed to pay $28 million to settle an antitrust suit brought by three generic drug makers over the company’s patent infringement suits regarding the antidepressant Remeron.

The generic drug makers had sued Akzo in New Jersey district court, alleging that Akzo’s assertion of the patent delayed the market introduction of mirtazapine, the generic name of the drug, and violated antitrust laws.

Akzo said it is in the process of concluding a tentative settlement with a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.